X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (451) 451
humans (375) 375
alzheimer's disease (334) 334
animals (278) 278
neurosciences (271) 271
presenilin-1 - genetics (250) 250
alzheimer disease - genetics (239) 239
mice (217) 217
amyloid beta-protein precursor - genetics (210) 210
presenilin-1 (192) 192
mice, transgenic (177) 177
male (172) 172
female (160) 160
alzheimer disease - metabolism (142) 142
alzheimer disease - pathology (137) 137
amyloid precursor protein (137) 137
disease models, animal (134) 134
amyloid beta-peptides - metabolism (130) 130
alzheimers-disease (126) 126
mutation (125) 125
clinical neurology (113) 113
amyloid beta-protein precursor - metabolism (107) 107
brain (102) 102
brain - metabolism (94) 94
presenilin-1 - metabolism (92) 92
transgenic mice (89) 89
cerebrospinal-fluid (88) 88
middle aged (87) 87
neurology (87) 87
a-beta (85) 85
dementia (85) 85
brain - pathology (80) 80
adult (78) 78
mutation - genetics (76) 76
aged (73) 73
in-vivo (73) 73
membrane proteins - genetics (72) 72
mice, inbred c57bl (72) 72
alzheimers disease (70) 70
amyloid beta-protein (61) 61
mouse model (61) 61
genetic aspects (60) 60
analysis (56) 56
biochemistry & molecular biology (56) 56
pathology (56) 56
proteins (54) 54
presenilin 1 (53) 53
alzheimer disease - cerebrospinal fluid (52) 52
alzheimer disease - physiopathology (52) 52
geriatrics & gerontology (52) 52
mild cognitive impairment (50) 50
alzheimer’s disease (49) 49
neurodegenerative diseases (49) 49
research (49) 49
amyloid precursor protein secretases - metabolism (48) 48
cerebrospinal fluid (48) 48
precursor protein (48) 48
amyloid beta-peptides - cerebrospinal fluid (46) 46
alzheimer disease - complications (44) 44
alzheimer disease - diagnosis (43) 43
protein (43) 43
alzheimer disease - drug therapy (42) 42
cell biology (42) 42
neurons - metabolism (42) 42
amyloid (41) 41
biomarkers (41) 41
hippocampus (41) 41
memory (41) 41
peptide fragments - metabolism (41) 41
aged, 80 and over (40) 40
diagnosis (39) 39
gene (39) 39
amyloid beta-peptides - genetics (38) 38
membrane proteins - metabolism (38) 38
presenilin (38) 38
synaptic plasticity (38) 38
apolipoproteins e - genetics (37) 37
gamma-secretase (37) 37
magnetic resonance imaging (37) 37
mental disorders (37) 37
neurons (37) 37
amyloid-beta (36) 36
cells, cultured (36) 36
expression (36) 36
long-term potentiation (36) 36
age (35) 35
app (35) 35
article (35) 35
rodents (35) 35
plaque, amyloid - pathology (34) 34
psychiatry (34) 34
apolipoprotein-e (33) 33
hippocampus - metabolism (33) 33
oxidative stress (33) 33
presenilin-2 - genetics (33) 33
deposition (32) 32
peptide (32) 32
genetic engineering (31) 31
plaque, amyloid - metabolism (31) 31
risk factors (31) 31
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2015, Volume 43, Issue 2, pp. 575 - 588
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2012, Volume 30, Issue 4, pp. 847 - 856
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2014, Volume 43, Issue 4, pp. 1393 - 1402
Journal Article
Journal Article
Molecular Neurodegeneration, ISSN 1750-1326, 09/2016, Volume 11, Issue 1, pp. 1 - 11
Presenilin-1 (PS1), the active component of the intramembrane [gamma]-secretase complex, can be detected as soluble heteromeric aggregates in cerebrospinal... 
Biomarker | Presenilin-1 | Mild-cognitive impairment | Pre-symptomatic | Cerebrospinal fluid | Down syndrome | Autosomal dominant Alzheimer's disease | Physiological aspects | Development and progression | Genetic aspects | Diagnosis | Research | Alzheimer's disease
Journal Article
Science Translational Medicine, ISSN 1946-6234, 03/2014, Volume 6, Issue 226, pp. 226ra30 - 226ra30
Journal Article
ANNALS OF NEUROLOGY, ISSN 0364-5134, 04/1999, Volume 45, Issue 4, pp. 504 - 511
All mutations known to cause familial Alzheimer's disease (AD) act by increasing the levels of soluble beta-amyloid peptide (A beta), especially the longer... 
DEMENTIA | CLINICAL-DIAGNOSIS | DEPOSITION | IN-VIVO | AMYLOID-BETA-PROTEIN | PRECURSOR PROTEIN | MUTATIONS | APOLIPOPROTEIN-E GENOTYPE | NEUROSCIENCES | PEPTIDE | CLINICAL NEUROLOGY | PRESENILIN-1
Journal Article